This year InSysBio celebrates its 20-year anniversary. During this period the company made the way from modeling in systems biology and biotechnology to pharmacometrics modeling services. Now InSysBio specializes in Quantitative Systems Pharmacology (QSP) modeling services and QSP software infrastructure development and operates in the global market.
InSysBio was founded in 2004 and since then has evolved into a group of companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). Part of InSysBio team relocated to Limassol, Cyprus after the start of operation of new Headquarters there, thus, expanding the company’s presence.
InSysBio has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. This experience covers a wide range of therapeutic areas: inflammatory disease, autoimmune disease, diabetes and obesity, cardiovascular diseases, infectious diseases, metabolic diseases, diseases associated with kidney dysfunction, pain and rare diseases. Currently InSysBio mainly focuses on QSP models and platforms in immunology, oncology and immuno-oncology and neurodegenerative diseases.
InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The focus of projects went through a range of transformations on the way to QSP modeling services. Over the years of operation InSysBio carried out modeling in systems biology, then modeling of biotechnological processes and drug safety. Now InSysBio develops models of such types as mechanistic PK/PD, PK/RO, PBPK/RO, QSP fit for purpose, QSP platforms. The modality of services includes small molecule, mAb, bispecific and multispecific Ab, T cell engagers, Antibody Drug Conjugate, cell therapy, gene therapy.
Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, comments on InSysBio’s approach, “Over the past 20 years the perception of QSP has changed and the changes are still underway. For instance, a simple-minded view on QSP as a universal tool able to address a range of the issues of drug research and development is evolving into a pragmatic view on QSP as an approach to meet quite particular challenges. Our company is developing according to this evolvement. I hope at least part of these changes in the perception of QSP has occurred due to InSysBio’s proactive and consistent position. I suppose this will continue”.
In 2015 InSysBio started development of its QSP software infrastructure for external and internal usage. Since then, the infrastructure is being constantly updated and extended. The range of InSysBio’s tools and databases embraces Immune Response Template (IRT), Heta compiler, HetaSimulator.jl, CYTOCON DB, fIVE DB, DBSolveOptimum, SbmlViewer, LikelihoodProfiler. The implementation of QSP tools allows to simplify modeling process.
InSysBio continues the development of its QSP services and tools according to its mission, vision and values, namely, providing QSP modeling to world pharma, contributing our expertise to global QSP community and creating favorable atmosphere for self-development of researchers. Every year InSysBio team publishes their articles in scientific journals and presents at the most valuable industry conferences, namely, ACoP, SITC, PAGE, ASCPT, AAIC, QSPC etc. There are more than 150 papers and posters presented by InSysBio team now.
Moreover, InSysBio provides consultancy services and educational assistance to academic entities. Besides, InSysBio develops blog which core idea is to provide a unique collection of methodological materials on QSP modeling that has no analogue. The company’s diverse expertise and corporate philosophy were carefully reflected through rebranding twice at different stages if InSysBio’s development.
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | October 2018 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
1.
01 Oct 2018 12:23
InSysBio Announces Continuation of Collaboration with MedImmune for Quantitative Systems Pharmacology Modeling in Systemic Lupus Erythematosus
InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP), modeling and simulation for drug development, announced today an extension of a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, for QSP modeling in systemic lupus erythematosus (SLE). The goal is to support the clinical development of anifrolumab, an investigational monoclonal antibody against the type I interferon receptor, by modeling the contributions of key cell types involved in the pathophysiology of lupus that are associated with the type I interferon dysregulation commonly seen with the disease.
|
2
1.
02 Oct 2018 14:05
InSysBio to present at ACoP9
InSysBio announces their participation at Ninth American Conference on Pharmacometrics (ACoP9), to be held October 7th to 10th, 2018, at the Loews Coronado Bay Resort near San Diego, CA. The theme of ACoP9 is “Modeling without Bounds”. InSysBio welcomes visitors at the booth #23.
|
3
|
4
|
5
|
6
|
7
|
|
8
|
9
1.
09 Oct 2018 15:29
InSysBio starts training course “Modeling for systems biology and biomedicine”
InSysBio expert modelers Dr. Galina Lebedeva, Dr. Tatiana Karelina, Dr. Evgeny Metelkin and Dr. Oleg Demin will give the course “Modeling for systems biology and biomedicine” at the Faculty of bioengineering and bioinformatics, Lomonosov Moscow State University.
|
10
|
11
|
12
|
13
|
14
|
|
15
|
16
|
17
|
18
|
19
1.
19 Oct 2018 15:49
InSysBio to present at BiotechClub 2018
InSysBio announces their participation at BiotechClub 2018 conference to be held on October 26th at Hyatt Regency Moscow Petrovsky Park. The theme of BiotechClub 2018 is “From Systems Biology to Systems Medicine”.
|
20
|
21
|
|
22
|
23
|
24
1.
24 Oct 2018 13:49
InSysBio to present at ICSB 2018
InSysBio announces their participation at 19th International Conference on Systems Biology (ICSB 2018) to be held October 28th to November 1st, 2018 in Lyon, France.
|
25
|
26
|
27
|
28
|
|
29
|
30
|
31
| ||||
Thank you for your message! We will get back to you shortly.
